Longeveron Inc. (LGVN)
NASDAQ: LGVN · Real-Time Price · USD
0.9800
-0.1300 (-11.71%)
At close: Mar 20, 2026, 4:00 PM EDT
0.9836
+0.0036 (0.37%)
Pre-market: Mar 23, 2026, 4:06 AM EDT
Longeveron Market Cap
Longeveron has a market cap or net worth of $22.8 million as of March 20, 2026. Its market cap has increased by 5.86% in one year.
Market Cap
22.80M
Enterprise Value
18.97M
1-Year Change
5.86%
Ranking
Category
Stock Price
$0.98
Market Cap Chart
Since the IPO on February 12, 2021, Longeveron's market cap has decreased from $172.48M to $22.80M, a decrease of -86.78%. That is a compound annual growth rate of -32.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 28.70M | 165.84% |
| Dec 31, 2025 | 10.79M | -57.95% |
| Dec 31, 2024 | 25.67M | -24.83% |
| Dec 29, 2023 | 34.15M | -49.55% |
| Dec 30, 2022 | 67.68M | -72.36% |
| Dec 31, 2021 | 244.90M | 41.99% |
| Feb 12, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeuroSense Therapeutics | 25.15M |
| Neuphoria Therapeutics | 24.85M |
| Enlivex | 24.34M |
| Senti Biosciences | 24.19M |
| Vistagen Therapeutics | 24.13M |
| Passage Bio | 23.83M |
| Lantern Pharma | 23.82M |
| Marker Therapeutics | 22.34M |